Digital inhalers to report patient adherence

Integrated adherence monitors in asthma and COPD inhalers are on the horizon and clinicians should do all they can to support their development and adoption. A call-to-action, published in JAMA in response to recent FDA approval of the first such inhaler – Teva’s ProAir Digihaler (albuterol sulfate 117mcg) – said integrated adherence monitoring was ‘desirable, feasible ...

Already a member?

Login to keep reading.

© 2021 the limbic